Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Clinical and Translational Gastroenterology|July 7, 2018
A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitisTakayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, et al.Digestive Diseases and Sciences|August 9, 2015
An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's DiseaseKen Sugimoto, Kentaro Ikeya, Takayuki Iida, et al.Clinical and Translational Gastroenterology|October 13, 2018
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitisTakayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, et al.Clinical and Translational Gastroenterology|November 16, 2018
Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitisTakayuki Yamamoto, Takayuki Iida, Kentaro Ikeya, et al.The American Journal of Gastroenterology|August 17, 2004
Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitisHiroyuki Hanai, Fumitoshi Watanabe, Masami Yamada, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 1, 2012
Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's diseaseHiroyuki Hanai, Takayuki Iida, Ken Takeuchi, et al.Journal of Gastroenterology|March 22, 2017
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitisYasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.International Journal of Molecular Medicine|April 7, 2004
Germinated barley foodstuff prolongs remission in patients with ulcerative colitisHiroyuki Hanai, Osamu Kanauchi, Keiichi Mitsuyama, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 16, 2011
A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitisToshifumi Ashida, Yutaka Kohgo, Akihiro Munakata, et al.Journal of Gastroenterology|December 24, 2013
Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitisYasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.Pageof 7